Showing results (471-480 of 5,155) with videos related to
Sort By:
Pageof 516
Lancet (London, England)|July 26, 2012
Optimisation of HIV care and service delivery: doing more with lessMark A Boyd, David A CooperThe Biochemical Journal|June 1, 1972
The purification and properties of Escherichia coli methylglyoxal synthaseD J Hopper, R A CooperJournal of Bacteriology|June 1, 1974
Genetic studies on ribose 5-phosphate isomerase mutants of Escherichia coli K-12A J Skinner, R A CooperMethods in Molecular Biology (Clifton, N.J.)|March 26, 2010
The value of the dental impaction pain model in drug developmentStephen A Cooper, Paul J DesjardinsJournal of Hand Surgery (Edinburgh, Scotland)|October 1, 1985
Charcot's oedème bleu des hystériquesM A Cooper, D M DaviesInfectious Disease Reports|January 23, 2025
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent UseAditya K Gupta, Elizabeth A CooperAIDS (London, England)|August 1, 1990
Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. The Australian Zidovudine Study GroupC E Swanson, D A CooperCurrent Opinion in Cell Biology|February 3, 2009
Actin and endocytosis: mechanisms and phylogenyBrian J Galletta, John A CooperAnnual Review of Cell and Developmental Biology|January 1, 1995
Control of actin assembly at filament endsD A Schafer, J A CooperJournal of Bacteriology|July 1, 1980
Catabolism of 3- and 4-hydroxyphenylacetate by the 3,4-dihydroxyphenylacetate pathway in Escherichia coliR A Cooper, M A SkinnerPageof 516